Nasdaq · Biotech stocks database

AMRX — Amneal Pharmaceuticals Inc.

AMRX (Amneal Pharmaceuticals Inc.) stock: $18.71, $6.52B market cap, $127.6M cash, $8.95B EV, $6.30B fully diluted market cap. Data from Fully Diluted's biotech stocks database.

Share price

$18.71

Market cap

$6,516.6M

Cash

$127.6M

Enterprise value

$8,953.3M

Balance sheet

Cash	$127.6M
Debt	$2,564.3M
Net cash	-$2,436.7M
Enterprise value	$8,953.3M
Basic shares	328.1M shares
Fully diluted shares	336.5M shares
Fully diluted market cap	$6,295.4M
Cash per share	$0.39

Cash figures as of 2026-06-30. Database snapshot: 2026-09-21.

Price history

Loading AMRX daily closes…

Loading price history…

Active clinical trials

Trial	Phase	Status	Role	Sponsor	BP	Condition(s)	Mgmt guide
NCT01733082	Not disclosed	Recruiting	Collaborator	Genentech, Inc.	NVS	Heart Transplantation, Kidney Transplantation, Liver Transplantation,	—
NCT00404989	Not disclosed	Recruiting	Collaborator	Syneos Health	ABBV, BMY, GILD, JNJ, MRK	HIV Infections; Hepatitis B	—

Sponsor-matched active trials from ClinicalTrials.gov (0 as sponsor, 2 as collaborator); "Sponsor" = company is the lead sponsor, "Collaborator" = company is a collaborator. The BP column flags big-pharma involvement as lead sponsor or collaborator (excluding the company itself). The Mgmt guide column shows what management guided for readout timing when a guided program matches the trial (hover for the quote, click for the source). Trial listings are not a company pipeline slide.

View all 2 active trials for Genentech, Inc. on ClinicalTrials.gov

Get the weekly biotech catalyst rundown.
Cash runways, financings, and trial readouts for all 714 stocks.

Subscribe to Compounding Ego